Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
HyperAcute Lung, tergenpumatucel-L
print preview
bookmark
share with colleague
General Information
Company
NewLink Genetics Corp.
Description
Alpha 1,3-galactosyltransferase-expressing allogeneic lung tumor cell vaccine
Molecular Target
Mechanism of Action
Vaccine
Latest Stage of Development
Phase II/III
Indication
Non-small cell lung cancer (NSCLC)
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy